Verana Health and HealthVerity partner to enhance clinical insights with real-world evidence

Verana Health and HealthVerity will work together to integrate registry real-world data (RWD), enhancing clinical research and patient care in ophthalmology, urology and neurology.

Verana Health and HealthVerity have announced a strategic partnership aimed at revolutionizing patient care and clinical research through RWD. This collaboration, part of the Preferred Data Partner Program, will expand access to critical healthcare data in ophthalmology, urology and neurology by integrating Verana Health’s curated registry data into the HealthVerity Marketplace.

Verana Health’s RWD network includes over 20,000 healthcare clinicians and 90 million de-identified patients, derived from strategic data partnerships with leading medical societies. The company utilizes physician expertise and AI to unlock the true potential of RWD, powering real-world evidence (RWE) generation.

HealthVerity integrates advanced technologies with the largest healthcare and consumer data ecosystem in the US. Their approach is based on the foundational elements of identity, privacy, governance and exchange (IPGE), ensuring robust identity management alongside built-in privacy compliance and governance.

The partnership will enable deeper insights and foster innovation in patient care by making Verana Health’s curated registry data available in a de-identified and HIPAA-compliant manner on the HealthVerity Marketplace. This self-service cloud solution allows users to explore extensive healthcare and consumer data, providing real-time patient counts and data provider overlaps.

Sujay Jadhav, CEO of Verana Health commented,

“By partnering with HealthVerity, we can amplify our ability to harness the power of RWD to accelerate advancements in health care. Our shared vision is to enhance the quality of care and life for patients through data-driven insights and solutions.”

The Preferred Data Partner Program empowers leading organizations to augment their research, analyses, and data-driven solutions with unique, de-identified elements of Verana Health’s extensive healthcare datasets. This access is crucial for conducting more in-depth, accurate, and current analyses essential to advancing patient care and clinical research.

Andrew Kress, CEO of HealthVerity, highlighted the importance of this partnership, stating,

“We are excited to partner with Verana Health to offer exclusive data from leading medical societies that will enable a better understanding of the patient journey for numerous conditions that impact millions, such as AMD, thyroid eye disease, spinal muscular atrophy, Alzheimer’s disease, and bladder and prostate cancer. This partnership is part of our ongoing efforts to bring the most novel RWD sources to our ever-growing healthcare data ecosystem to help our clients advance the science.”